Cannabis & Inflammatory Bowel Disease
Published: Journal of Cannabis Research, June 2026
Researchers: Jugl, Perez-Vilar, Galati et al. — University of Florida / US Food and Drug Administration — systematic review
1. What Was Studied?
Inflammatory bowel disease (IBD) — which includes Crohn's disease and ulcerative colitis — is a chronic condition causing inflammation of the digestive tract, resulting in pain, diarrhea, fatigue, and significant quality of life impact. Between 11% and 17% of IBD patients report using cannabis for symptom management.
This systematic review examined all available evidence on THC-containing cannabis specifically for IBD — a deliberate focus on the cannabinoid most commonly used by patients rather than CBD alone. Researchers from the University of Florida and the FDA reviewed clinical trials, cohort studies, and real-world data.
2. What Did They Find?
THC-containing cannabis was associated with meaningful reductions in Crohn's Disease Activity Index scores across multiple studies — the key clinical measure of Crohn's severity
IBD patients using cannabis were significantly less likely to require surgery, parenteral nutrition, or colectomy compared to non-users in real-world cohort studies
Patient-reported outcomes — including pain, stool frequency, emotional distress, and appetite — consistently improved with cannabis use
However, evidence for endoscopic improvement (actual healing of the bowel lining visible on colonoscopy) was not demonstrated in controlled trials — meaning cannabis appeared to reduce symptoms without necessarily reducing underlying inflammation on camera
The clinical-endoscopic disconnect is a key and recurring finding in IBD cannabis research
3. What This Means
The symptom relief case for cannabis in IBD is meaningful and consistent across a broad evidence base. Pain, urgency, appetite, and emotional wellbeing all improving is real and important quality of life benefit for people with a chronic condition that profoundly affects daily life.
The endoscopic finding — that symptoms improved without visible bowel healing — is the honest nuance that matters. Cannabis may help people feel significantly better without necessarily treating the underlying disease process. That's not nothing, but it's an important distinction for anyone using cannabis alongside (or instead of) conventional IBD therapies.
4. What This Does NOT Mean
Cannabis does not treat or cure IBD
Symptom improvement without endoscopic remission means the underlying disease may still be progressing even when people feel better
Cannabis should not replace established IBD therapies like biologics or immunosuppressants without specialist guidance
The surgical outcome data comes from observational studies — correlation, not proven cause and effect
THC-containing products carry psychoactive and dependency considerations not covered in this review
5. Bottom Line
A 2026 systematic review found THC-containing cannabis consistently improved IBD symptoms and was associated with fewer surgeries in real-world data — but controlled trials found no evidence of actual bowel healing, making the clinical picture more complex than symptom scores alone suggest.
🗣️ Mary Jane's Take
The symptom vs. healing distinction is one of the most important things to understand in cannabis and IBD research. Feeling better is real and worth something. But if the disease is still progressing underneath, that needs to be part of the conversation with your gastroenterologist.
